Connect your AI

Organogenesis Holdings Inc. ORGO Price / book

Price / book at other companies

IAR

Integra LifeSciencesIART

0.7×-0.4×

MiMedx GroupMDXG

2.4×-3.1×

Orthofix Medical Inc.OFIX

1.1×-0.3×

BioventusBVS

3.3×-0.8×

ArtivionAORT

3.9×+0.4×

AxogenAXGN

7×-0.8×

Other financials

Income statement

Revenue$37.2M-57.1%

Gross profit$63.0M-22.5%

Operating income-$68.9M-158%

Net income-$53.2M-182%

EPS (diluted)-$0.44-159%

Balance sheet

Cash & equivalents$91.4M-16.9%

Total debt$39.4M+24.8%

Total equity$244.6M+0.7%

Total assets$520.0M+11.3%

Cash flow

Operating cash flow$21.1M+206%

CapEx$3.1M-13.2%

Free cash flow$18.0M+176%

Valuation

Market cap$312.68M-23.7%

Enterprise value$260.72M-21.3%

P/E115×—

P/S0.6×-0.3×

Profitability

Gross margin75.9%+0.8pp

Operating margin0.5%—

Net margin0.5%+0.3pp

FCF margin6.9%—

Returns & leverage

Return on equity1.1%+0.6pp

Debt / equity0.2×0.0×

Current ratio3.5×-0.6×

Where this comes from

Calculated from Organogenesis Holdings Inc.’s reported figures.

market cap/total stockholders equity=1.2×

Based on the most recent quarter.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Organogenesis Holdings Inc.'s price / book?: Organogenesis Holdings Inc. (ORGO) reported price / book of 1.2× in Q1 2026.
How has Organogenesis Holdings Inc.'s price / book changed year-over-year?: Organogenesis Holdings Inc.'s price / book decreased by 44.7% year-over-year, from 2.3× to 1.2×.
What is the long-term trend for Organogenesis Holdings Inc.'s price / book?: Over 5 years (2020 to 2025), Organogenesis Holdings Inc.'s price / book has grown at a -20.2% compound annual growth rate (CAGR), from 6.8× to 2.2×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.